Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
-
* Corresponding author: José M Navarro-Jarabo jnavarro@hcs.es
BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31
Accesses
- Last 30 days: 40 accesses
- Last 365 days: 608 accesses
- All time: 5570 accesses